News
12d
News-Medical.Net on MSNRare sugars curb appetite and mimic diabetes drugs in miceRare sugars like D-allulose, D-tagatose, and D-sorbose significantly boosted GLP-1 secretion and suppressed food intake in ...
The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...
GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.
Advances recognized by science’s most lucrative awards include high-energy physics experiments and groundbreaking weight-loss ...
Xeris Biopharma Holdings, Inc.’s XERS share price has dipped by 7.38%, which has investors questioning if this is right time ...
Originally developed to treat diabetes, these drugs work by mimicking a hormone called glucagon-like peptide 1 (GLP-1), which ...
26d
The Brighterside of News on MSNEco-friendly weight loss: Grow Ozempic-like medication at homeThe team uses Nicotiana benthamiana, a species of tobacco, to generate Glucagon-like Peptide-1 ... which relies on chemical ...
The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of ... and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia ...
By promoting collagen synthesis, Vitamin C contributes to the ... In recent years, GLP-1 (glucagon-like peptide-1) medications have gained considerable attention as effective treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results